share_log

Insider Sale: Chief Financial Officer of $BRFH (BRFH) Sells 200 Shares

Quiver Quantitative ·  Dec 16, 2024 18:45

Lisa Roger, the Chief Financial Officer of $BRFH ($BRFH), sold 200 shares of the company on 12-16-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares. Following this trade, they now own 76,428 shares of $BRFH stock.

$BRFH Insider Trading Activity

$BRFH insiders have traded $BRFH stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here's a breakdown of recent trading of $BRFH stock by insiders over the last 6 months:

  • LISA ROGER (Chief Financial Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 4,522 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BRFH Hedge Fund Activity

We have seen 7 institutional investors add shares of $BRFH stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • HIGHTOWER ADVISORS, LLC added 35,363 shares (+37.4%) to their portfolio in Q3 2024
  • MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. added 21,398 shares (+inf%) to their portfolio in Q3 2024
  • CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. removed 10,000 shares (-100.0%) from their portfolio in Q2 2024
  • UBS GROUP AG added 9,550 shares (+512.6%) to their portfolio in Q3 2024
  • GEODE CAPITAL MANAGEMENT, LLC added 7,718 shares (+9.4%) to their portfolio in Q3 2024
  • TOWER RESEARCH CAPITAL LLC (TRC) removed 411 shares (-21.8%) from their portfolio in Q3 2024
  • NEWEDGE ADVISORS, LLC added 209 shares (+68.8%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment